Moscow [Russia], August 23 (ANI): Russia's Gamaleya National Research Center of Epidemiology and Microbiology (Gamaleya Center) and the Russian Direct Investment Fund announced the development of the Sputnik V vaccine specifically adapted against Delta and Omicron variants of coronavirus.
Moscow [Russia], May 24 (ANI): Gamaleya National Research Center of Epidemiology and Microbiology on Wednesday said that Sputnik V demonstrated strong protection against Omicron variant of COVID-19.
Moscow [Russia], December 11 (ANI/Sputnik): Patients infected with the Omicron variant of COVID-19, who arrived in Russia from South Africa, were earlier vaccinated, their disease is mild, Alexander Gintsburg, director of Russia's Gamaleya National Research Center of Epidemiology and Micr
New Delhi [India], July 12 (ANI): The Gamaleya National Research Center of Epidemiology and Microbiology and the Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund) on Monday announced strong results of the study on neutralizing the activity of sera from individuals vacc
Moscow [Russia], September 8 (ANI/Sputnik): The first batch of the Sputnik V vaccine against COVID-19, developed by Russia's Gamaleya National Research Center of Epidemiology and Microbiology and the Russian Direct Investment Fund (RDIF) has been released into civil circulation, regional del